St. Jude Medical CEO says devices for atrial fibrillation to boost growth

02/6/2011 | Reuters

St. Jude Medical CEO Daniel Starks said he believes the company will continue to experience sales growth, driven by new pacemakers and other cardiac-rhythm management devices that are designed to treat atrial fibrillation. The company said it has sufficient cash to buy back shares and acquire companies.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI